The FDA has finalized a divisive plan to regulate some lab tests, including those used to diagnose cancer and Alzheimer’s disease, over concerns about reliability and risk to patients. Read this story
The FDA has finalized a divisive plan to regulate some lab tests, including those used to diagnose cancer and Alzheimer’s disease, over concerns about reliability and risk to patients. Read this story
More from Washington Post | Food and Drug Administration Laboratory developed test Medicine Health care